These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 15694663)

  • 21. Monoclonal antibodies labeled with rhenium-186 using the MAG3 chelate: relationship between the number of chelated groups and biodistribution characteristics.
    van Gog FB; Visser GW; Klok R; van der Schors R; Snow GB; van Dongen GA
    J Nucl Med; 1996 Feb; 37(2):352-62. PubMed ID: 8667076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 5-FU uptake in peritoneal metastases after pretreatment with radioimmunotherapy or vasoconstriction: an autoradiographic study in the rat.
    Mahteme H; Sundin A; Larsson B; Khamis H; Arow K; Graf W
    Anticancer Res; 2005; 25(2A):917-22. PubMed ID: 15868928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experimental radioimmunotherapy with 186Re-MAG3-A7 anti-colorectal cancer monoclonal antibody: comparison with 131I-counterpart.
    Kinuya S; Yokoyama K; Kobayashi K; Motoishi S; Onoma K; Watanabe N; Shuke N; Bunko H; Michigishi T; Tonami N
    Ann Nucl Med; 2001 Jun; 15(3):199-202. PubMed ID: 11545188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radioimmunotherapy of carcinoma of colon with [131I]-labeled recombinant chimeric monoclonal antibodies to carcinoembryonic antigen.
    Lu QJ; Bian GX; Chen YY; Zhang M; Guo SM; Wen LQ
    Acta Pharmacol Sin; 2005 Oct; 26(10):1259-64. PubMed ID: 16174444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Timing effects of combined radioimmunotherapy and radiotherapy on a human solid tumor in nude mice.
    Sun LQ; Vogel CA; Mirimanoff RO; Coucke P; Slosman DO; Mach JP; Buchegger F
    Cancer Res; 1997 Apr; 57(7):1312-9. PubMed ID: 9102219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two-step targeting of xenografted colon carcinoma using a bispecific antibody and 188Re-labeled bivalent hapten: biodistribution and dosimetry studies.
    Gestin JF; Loussouarn A; Bardiès M; Gautherot E; Gruaz-Guyon A; Saï-Maurel C; Barbet J; Curtet C; Chatal JF; Faivre-Chauvet A
    J Nucl Med; 2001 Jan; 42(1):146-53. PubMed ID: 11197965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of copper-67- and iodine-125-labeled anti-CEA monoclonal antibody biodistribution in patients with colorectal tumors.
    Delaloye AB; Delaloye B; Buchegger F; Vogel CA; Gillet M; Mach JP; Smith A; Schubiger PA
    J Nucl Med; 1997 Jun; 38(6):847-53. PubMed ID: 9189128
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reconciliation of tumor dose response to external beam radiotherapy versus radioimmunotherapy with 131iodine-labeled antibody for a colon cancer model.
    Roberson PL; Buchsbaum DJ
    Cancer Res; 1995 Dec; 55(23 Suppl):5811s-5816s. PubMed ID: 7493351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of multiple, repeated doses of radioimmunotherapy on target antigen expression (breast MUC-1 mucin) in breast carcinomas.
    Peterson JA; Blank EW; Ceriani RL
    Cancer Res; 1997 Mar; 57(6):1103-8. PubMed ID: 9067279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics and normal organ dosimetry following intraperitoneal rhenium-186-labeled monoclonal antibody.
    Breitz HB; Durham JS; Fisher DR; Weiden PL; DeNardo GL; Goodgold HM; Nelp WB
    J Nucl Med; 1995 May; 36(5):754-61. PubMed ID: 7738644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Computational model predicts effective delivery of 188-Re-labeled melanin-binding antibody to metastatic melanoma tumors with wide range of melanin concentrations.
    Schweitzer AD; Rakesh V; Revskaya E; Datta A; Casadevall A; Dadachova E
    Melanoma Res; 2007 Oct; 17(5):291-303. PubMed ID: 17885584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A phase I trial of a rhenium 186-labeled monoclonal antibody administered intraperitoneally in ovarian carcinoma: toxicity and clinical response.
    Jacobs AJ; Fer M; Su FM; Breitz H; Thompson J; Goodgold H; Cain J; Heaps J; Weiden P
    Obstet Gynecol; 1993 Oct; 82(4 Pt 1):586-93. PubMed ID: 8377986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rhenium-186-labeled monoclonal antibodies for radioimmunotherapy: preparation and evaluation.
    John E; Thakur ML; DeFulvio J; McDevitt MR; Damjanov I
    J Nucl Med; 1993 Feb; 34(2):260-7. PubMed ID: 8429345
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radioimmunotherapy of human colon carcinoma xenografts using a 213Bi-labeled domain-deleted humanized monoclonal antibody.
    Milenic D; Garmestani K; Dadachova E; Chappell L; Albert P; Hill D; Schlom J; Brechbiel M
    Cancer Biother Radiopharm; 2004 Apr; 19(2):135-47. PubMed ID: 15186593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single-Dose versus fractionated radioimmunotherapy of human colon carcinoma xenografts using 131I-labeled multivalent CC49 single-chain fvs.
    Goel A; Augustine S; Baranowska-Kortylewicz J; Colcher D; Booth BJ; Pavlinkova G; Tempero M; Batra SK
    Clin Cancer Res; 2001 Jan; 7(1):175-84. PubMed ID: 11205906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radioimmunotherapy and fractionated radiotherapy of human colon cancer liver metastases in nude mice.
    Vogel CA; Galmiche MC; Buchegger F
    Cancer Res; 1997 Feb; 57(3):447-53. PubMed ID: 9012472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A phase II study of intraperitoneal radioimmunotherapy with iodine-131-labeled monoclonal antibody OC-125 in patients with residual ovarian carcinoma.
    Mahé MA; Fumoleau P; Fabbro M; Guastalla JP; Faurous P; Chauvot P; Chetanoud L; Classe JM; Rouanet P; Chatal JF
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3249s-3253s. PubMed ID: 10541371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic efficacy and tumor dose estimations in radioimmunotherapy of intraperitoneally growing OVCAR-3 cells in nude mice with (211)At-labeled monoclonal antibody MX35.
    Elgqvist J; Andersson H; Bäck T; Hultborn R; Jensen H; Karlsson B; Lindegren S; Palm S; Warnhammar E; Jacobsson L
    J Nucl Med; 2005 Nov; 46(11):1907-15. PubMed ID: 16269606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor retention of 186Re-MAG3, 111In-DTPA and 125I labeled monoclonal antibody G250 in nude mice with renal cell carcinoma xenografts.
    Steffens MG; Kranenborg MH; Boerman OC; Zegwaart-Hagemeier NE; Debruyne FM; Corstens FH; Oosterwijk E
    Cancer Biother Radiopharm; 1998 Apr; 13(2):133-9. PubMed ID: 10850349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intraperitoneal radioimmunotherapy in an ovarian carcinoma mouse model: Effect of the radionuclide.
    Janssen ML; Pels W; Massuger LF; Oyen WJ; Boonstra H; Corstens FH; Boerman OC
    Int J Gynecol Cancer; 2003; 13(5):607-13. PubMed ID: 14675343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.